logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Dental Sleep Medicine Market, By Type (pap therapy, oral and nasal devices, other devices, drugs, airway systems, polysomnography and polygraphy, surgery, oximetry and actigraph) By End User (home, hospitals, sleep laboratories) opportunities and forecast 2020-2027

  • DLR2161
  • 23 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Long working hours, inactive lifestyles, experience to noise and light pollution such as consuming bright lights can all take the toll on one’s sleep patterns by the impacting their health, general quality of the life and well-being. People suffer from sleep disorders including sleep apnea and obstructive sleep apnea (OSA). OSA occurs due to couple of factors including family history of diabetes, asthma, smoking, narrowed airway, hypertension, and excess weight.
The dental sleep medicine is crucial part of the dentistry where the dentists are mainly concentrated to treat sleep-disordered breathing by using oral appliance therapy. The therapy includes use of device which is worn in mouth during sleep. Dental device fits as orthodontic retainer or sports mouth guard and its vital purpose is in keeping airway open particularly during sleep to prevent same from collapsing and blocking normal air flow during breathing.

Segment Overview

Respiratory polygraphy and polysomnography remains gold standard sleep medicine diagnostics. However, the market share is being progressively threatened by rise of home based and portable systems due to the ease of use and accuracy and efficiency. The use of innovative software in the product is prime cause of rise in accuracy and efficiency. Though, Oximetry is the faster and portable, but produce less inaccurate and sensitive results.

Regional Overview

Europe holds second largest share in market and can be linked to the factors such as outline of advanced products, focus of industry players and growing government support. Asia Pacific region is projected to see fastest growth in dental sleep medicine market owing to the massive patient pool, demand for the latest treatment options and the growing healthcare spending. Middle East and Africa owing to the huge unmet needs is projected to show faster growth for both the high tech and low-tech products during assessment period.

The awaited dental sleep medicine occasion, North American Dental Medicine Symposium of 2019 hosted by the Dental Sleep Solutions held from 15-16th Feb, 2019. The main agenda of the event was bringing together host of dental sleep colleagues in the same roof to learn means to do more, do same better from leaders in the field.

Competitor overview

April 2018, the Leading national dentists’ society, American Academy of the Dental Sleep Medicine (AADSM) announced the comprehensive educational program, the AADSM Mastery Program that will make sure the dentists possess needed training and skills to offer to the patients experiencing sleep-related disorder including OSA and snoring with the proper oral appliance therapy (OAT).

March 2018, the global giant in the healthcare technology, Royal Philips declared launch of its third mask decision, DreamWear Full face that will be better choice for the patients with the sleep apnea who breathe with the mouth. The specialty of the face mask is that it’s been specially built with complete understanding of facial geometries using exclusive design processes and the tools to offer the patients with seal, fit, and comfort which is clinically proven.

Key Players
  1. Philips Healthcare and Teleflex, Inc,
  2. Invacare Corporation,
  3. Fisher & Paykel Healthcare,
  4. Curative Medical Inc.,
  5. Compumedics Limited,
  6. CareFusion Corp,
  7. Cadwell Laboratories Inc.,
  8. Braebon Medical Corporation,
  9. GE Healthcare
  10. BMC Medical Co., Ltd.
Market Segmentation

By Treatment & Diagnostics
  • Positive Airway Pressure (Pap) Therapy
  • Oral And Nasal Devices
  • Airway Systems
  • Other Devices,
  • Drugs,
  • Surgery,
  • Polysomnography And Polygraphy,
  • Oximetry
  • Actigraph
By End User
  • Home,
  • Sleep Laboratories
  • Hospitals
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 9

    2 Introduction 12

    • 2.1 Scope of Study 12
    • 2.2 Research Objective 12
    • 2.3 Assumptions & Limitations 13
      • 2.3.1 Assumptions 13
      • 2.3.2 Limitations 13
    • 2.4 Market Structure 13

    3 Research Methodology 14

    • 3.1 Research Process 14
    • 3.2 Primary Research 15
    • 3.3 Secondary Research 15

    4 Market Factor Analysis 16

    • 4.1 Porter’s Five Force Analysis 16
      • 4.1.1 Bargaining Power of Buyer 17
      • 4.1.2 Bargaining Power of Supplier 17
      • 4.1.3 Threat from Substitute 18
      • 4.1.4 Threat from a New Entrant 18
      • 4.1.5 Intensity of Competitive Rivalry 18
    • 4.2 Value Chain Analysis 19
      • 4.2.1 Device Manufacturers 19
      • 4.2.2 Software Developers 19
      • 4.2.3 Healthcare Providers 19
      • 4.2.4 Patients 19

    5 Market Dynamics 20

    • 5.1 Introduction 20
    • 5.2 Drivers 21
      • 5.2.1 Rise in risk factors is propelling the market growth 21
      • 5.2.2 Rise in diseases and growing geriatrics population 21
      • 5.2.3 Unmet needs 21
      • 5.2.4 Growing awareness of sleep disorders 21
      • 5.2.5 Technological advancements 22
    • 5.3 Restraints 22
      • 5.3.1 High cost and scanty presence of sleep labs 22
      • 5.3.2 Late awareness and discomfort 22
      • 5.3.3 Long-term dental changes 23
      • 5.3.4 Lack of effectiveness and efficacy 23
    • 5.4 Opportunities 23
      • 5.4.1 Untapped market 23
      • 5.4.2 Research and development 23
      • 5.4.3 Personalized and customised solutions 24
      • 5.4.4 Connected solutions and cloud based systems 24
    • 5.5 Challenges 24
      • 5.5.1 Poor standardization 24
      • 5.5.2 Sub-standard products 25

    6 Global Dental Sleep Medicine Market, By Treatment & Diagnostics 26

    • 6.1 Introduction 26
    • 6.2 Treatments 28
    • 6.3 Diagnostics 29

    7 Global Dental Sleep Medicine Market, By End Users 30

    • 7.1 Introduction 30
    • 7.2 Hospitals & Sleep Laboratories 31
    • 7.3 Home 32

    8 Global Dental Sleep Medicine Market, By Region 33

    • 8.1 Introduction 33
    • 8.2 North America 34
      • 8.2.1 U.S. 36
      • 8.2.2 Canada 38
    • 8.3 Europe 39
      • 8.3.1 Germany 41
      • 8.3.2 France 43
      • 8.3.3 U.K. 44
      • 8.3.4 Italy 46
      • 8.3.5 Spain 47
      • 8.3.6 Rest of Europe 49
    • 8.4 Asia Pacific 50
      • 8.4.1 Japan 53
      • 8.4.2 China 54
      • 8.4.3 India 56
      • 8.4.4 Australia 57
      • 8.4.5 Republic of Korea 59
      • 8.4.6 Rest of Asia Pacific 60
    • 8.5 Middle East and Africa 62
      • 8.5.1 Middle East 64
      • 8.5.2 Africa 66

    9 Company Profiling 68

    • 9.1 Koninklijke Philips N.V. 68
      • 9.1.1 Company Overview 68
      • 9.1.2 Financial Overview 69
      • 9.1.3 Key Developments 70
      • 9.1.4 SWOT Analysis 71
    • 9.2 ResMed 72
      • 9.2.1 Company Overview 72
      • 9.2.2 Financial Overview 72
      • 9.2.3 Key Developments 73
      • 9.2.4 SWOT Analysis 73
    • 9.3 Fisher & Paykel Healthcare 74
      • 9.3.1 Company Overview 74
      • 9.3.2 Financial Overview 74
      • 9.3.3 Key Developments 75
      • 9.3.4 SWOT Analysis 75
    • 9.4 Drive DeVilbiss Healthcare 76
      • 9.4.1 Company Overview 76
      • 9.4.2 Financial Overview 76
      • 9.4.3 Key Developments 76
      • 9.4.4 SWOT Analysis 77
    • 9.5 Curative Medical Inc. 78
      • 9.5.1 Company Overview 78
      • 9.5.2 Financial Overview 78
      • 9.5.3 Key Development 78
      • 9.5.4 SWOT Analysis 79
    • 9.6 Apex Medical Corporation 80
      • 9.6.1 Company Overview 80
      • 9.6.2 Financial Overview 80
      • 9.6.3 Key Developments 80
    • 9.7 BMC Medical Co. Ltd. 81
      • 9.7.1 Company Overview 81
      • 9.7.2 Financial Overview 81
    • 9.8 Becton, Dickinson and Company 82
      • 9.8.1 Company Overview 82
      • 9.8.2 Financial Overview 82
      • 9.8.3 Key Developments 82

    Report You Might be Interested